- Home
- SIGA vs MCI Comparison
SIGA vs MCI Comparison
Compare SIGA & MCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SIGA | MCI |
|---|---|---|
| Founded | 1995 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 471.2M | 408.6M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | SIGA | MCI |
|---|---|---|
| Price | $6.73 | $20.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 330.2K | 40.4K |
| Earning Date | 03-10-2026 | 01-01-0001 |
| Dividend Yield | ★ 9.01% | 8.46% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.03 | ★ 1.82 |
| Revenue | ★ $172,249,641.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $132.36 | N/A |
| P/E Ratio | ★ $6.47 | $9.88 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.95 | $12.96 |
| 52 Week High | $9.62 | $19.24 |
Technical Indicators
Market Signals| Indicator | SIGA | MCI |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 66.67 |
| Support Level | $6.41 | $18.65 |
| Resistance Level | $6.77 | $21.17 |
| Average True Range (ATR) | 0.22 | 0.64 |
| MACD | 0.02 | 0.29 |
| Stochastic Oscillator | 79.87 | 88.68 |
Price Performance
Historical ComparisonAbout SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About MCI Barings Corporate Investors
Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.